Startup ASEAN

COVATE PHARMA PTE. LTD.

View Website

Related Keywords

ACTIVE Healthcare & Education Biotechnology

Company Profile Briefs : Current drug development process is long, costly and unaffordable, APAC patients are typically included in the 2/3rd wave of launch countries. Leaves huge unmet need for the population residing in APAC. The high cost is mainly due to high failure rate during the later phases of clinical trials. Pandemic situation has posed further challenges on the current drug development and translation of new therapeutics to the clinic.Covate pharma, incorporate various tools such as Artificial intelligence, Biomarkers, precision medicine, in-silico Simulations and apply these to preclinical and clinical development to accelerate the development and therapeutics to clinic and achieve Proof of concept (POC) in the clinic. By accelerating the drug development, reducing the cost of development and enhancing the success rate, thereby making the medicines affordable to the patient and payers.Initial focus of drug development will be conditions of high unmet medical need in the APAC region, these include Tropical diseases such as Dengue, CNS conditions like Alzheimer’s and dementia. To Translate and accelerate the drug development ideas. Bridge the gaps, translate the great sciences into drugs in collaboration with the local ecosystem, thereby contributing to one which is vibrant and serves the needs of patients.

Overview

Website

Founded Date

2021-04-22

Company Size

Company Stage

Industry

Healthcare & Education

Technology

Biotechnology

Client Focus

B2B

Status

ACTIVE